Sources | Names Used |
---|---|
CTRPv2 | navitoclax:MST-312 (1:1 mol/mol) |
PharmacoGx | navitoclax:MST-312 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | ABL1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | AC003002.6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | AC003006.7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | AC004076.9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | AC004953.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AC005281.1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AC006386.1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | AC006486.9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |